There are no alternative auto-injectors available on the market in Canada for patients at risk of having an allergic reaction. Pfizer Canada said it is “working closely with its distributors to resolve the shortages as soon as possible,” but that “it expects a period of between two and four weeks of no inventory for the 0.3 mg format.”
The company added that usually people should avoid using expired EpiPens but given the circumstances, if someone is experiencing anaphylactic shock, caretakers should use the expired product and immediately call 911.
On June 4-5, DeviceTalks is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring, bringing you the best and brightest minds in the industry.
Heidi Dohse: Sr. Program Manager, Healthcare, Google, Founder, Tour de Heart Foundation, Acessa Health Inc. Michael J. Pederson: Senior Vice President, Cardiac Arrhythmias and Heart Failure Division, Abbott Hon. Melvin Carter: Mayor, Saint Paul Tim Philips: Compliance Officer, FDA’s Office of Medical Device and Radiological Health Operations Dr. Myriam J. Curet, MD, FACS: Chief Medical Officer, Intuitive Surgical
Take a look at our incredible line up of speakers and join us now.
Use the code "KEYNOTE" to save 15% on the cost of registration.